Trial Outcomes & Findings for Bicarbonate in Patients With Out-of-hospital Cardiac Arrest (NCT NCT02303548)
NCT ID: NCT02303548
Last Updated: 2022-03-25
Results Overview
Percentage of Participants with Return of Spontaneous Circulation (ROSC)
Recruitment status
COMPLETED
Study phase
PHASE2
Target enrollment
50 participants
Primary outcome timeframe
checked during CPR, duration of ROSC >20 min
Results posted on
2022-03-25
Participant Flow
Participant milestones
| Measure |
1 (Sodium Bicarbonate)
Sodium bicarbonate 50cc (50mEq) intravenous injection over 2 min
Sodium bicarbonate: Administer Sodium bicarbonate 50 mEq IV over 2 minutes
|
2 (Normal Saline)
Normal saline 50cc intravenous injection over 2 min
Normal saline: Placebo
|
|---|---|---|
|
Overall Study
STARTED
|
25
|
25
|
|
Overall Study
COMPLETED
|
25
|
25
|
|
Overall Study
NOT COMPLETED
|
0
|
0
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Race and Ethnicity were not collected from any participant.
Baseline characteristics by cohort
| Measure |
1 (Sodium Bicarbonate)
n=25 Participants
Sodium bicarbonate 50cc (50mEq) intravenous injection over 2 min
Sodium bicarbonate: Administer Sodium bicarbonate 50 mEq IV over 2 minutes
|
2 (Normal Saline)
n=25 Participants
Normal saline 50cc intravenous injection over 2 min
Normal saline: Placebo
|
Total
n=50 Participants
Total of all reporting groups
|
|---|---|---|---|
|
Age, Continuous
|
65.5 years
STANDARD_DEVIATION 16.4 • n=25 Participants
|
64.1 years
STANDARD_DEVIATION 15.4 • n=25 Participants
|
64.8 years
STANDARD_DEVIATION 16.0 • n=50 Participants
|
|
Sex: Female, Male
Female
|
7 Participants
n=25 Participants
|
4 Participants
n=25 Participants
|
11 Participants
n=50 Participants
|
|
Sex: Female, Male
Male
|
18 Participants
n=25 Participants
|
21 Participants
n=25 Participants
|
39 Participants
n=50 Participants
|
|
Race and Ethnicity Not Collected
|
—
|
—
|
0 Participants
Race and Ethnicity were not collected from any participant.
|
|
Region of Enrollment
South Korea
|
25 Participants
n=25 Participants
|
25 Participants
n=25 Participants
|
50 Participants
n=50 Participants
|
|
pH
|
6.99 units on a scale
n=25 Participants
|
6.90 units on a scale
n=25 Participants
|
6.95 units on a scale
n=50 Participants
|
|
Shockable pre-hospital rhythm
|
7 participants
n=25 Participants
|
3 participants
n=25 Participants
|
10 participants
n=50 Participants
|
PRIMARY outcome
Timeframe: checked during CPR, duration of ROSC >20 minPercentage of Participants with Return of Spontaneous Circulation (ROSC)
Outcome measures
| Measure |
1 (Sodium Bicarbonate)
n=25 Participants
Sodium bicarbonate 50cc (50mEq) intravenous injection over 2 min
Sodium bicarbonate: Administer Sodium bicarbonate 50 mEq IV over 2 minutes
|
2 (Normal Saline)
n=25 Participants
Normal saline 50cc intravenous injection over 2 min
Normal saline: Placebo
|
|---|---|---|
|
Return of Spontaneous Circulation (ROSC)
|
4 ROSC percents of each group
|
16 ROSC percents of each group
|
Adverse Events
1 (Sodium Bicarbonate)
Serious events: 25 serious events
Other events: 25 other events
Deaths: 24 deaths
2 (Normal Saline)
Serious events: 24 serious events
Other events: 25 other events
Deaths: 21 deaths
Serious adverse events
| Measure |
1 (Sodium Bicarbonate)
n=25 participants at risk
Sodium bicarbonate 50cc (50mEq) intravenous injection over 2 min
Sodium bicarbonate: Administer Sodium bicarbonate 50 mEq IV over 2 minutes
|
2 (Normal Saline)
n=25 participants at risk
Normal saline 50cc intravenous injection over 2 min
Normal saline: Placebo
|
|---|---|---|
|
Nervous system disorders
Severe hypoxic brain injury
|
100.0%
25/25 • Number of events 25
|
96.0%
24/25 • Number of events 24
|
Other adverse events
| Measure |
1 (Sodium Bicarbonate)
n=25 participants at risk
Sodium bicarbonate 50cc (50mEq) intravenous injection over 2 min
Sodium bicarbonate: Administer Sodium bicarbonate 50 mEq IV over 2 minutes
|
2 (Normal Saline)
n=25 participants at risk
Normal saline 50cc intravenous injection over 2 min
Normal saline: Placebo
|
|---|---|---|
|
Nervous system disorders
Severe hypoxic brain injury (<6 mo)
|
100.0%
25/25 • Number of events 25
|
100.0%
25/25 • Number of events 25
|
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place